focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: ReNeuron Chair And Other Board Members Buy Shares

Thu, 11th Apr 2019 18:24

LONDON (Alliance News) - ReNeuron Group PLC said a number of directors purchased shares on Thursday, including Non-Executive Chair John Berriman who bought 80,000 shares at 225 pence each.

On Thursday, shares in ReNeuron closed up 12% at 241.00p.

Berriman's GBP180,000 purchase took his total interest in the cell-based therapeutics developer to 90,434 shares or a 0.3% stake.

Simon Cartmell, a non-executive director, bought 7,758 shares at 225.55p each for GBP17,498, taking his interest to 15,633 shares or a 0.05% stake.

Another non-executive director, Chris Evans, bought 4,500 shares at 221.5p each for GBP9,967, lifting his interest to 244,605 shares or a 0.8% stake, and Non-Executive Director Mike Owen bought 4,237 - his entire holding and a 0.01% stake - for 236p per share for GBP9,999.

More News
18 Aug 2015 15:04

AGM, EGM Calendar - Week Ahead

Read more
18 Aug 2015 05:10

AGM, EGM Calendar - Week Ahead

Read more
17 Aug 2015 15:08

AGM, EGM Calendar - Week Ahead

Read more
17 Aug 2015 05:19

AGM, EGM Calendar - Week Ahead

Read more
14 Aug 2015 14:56

AGM, EGM Calendar - Week Ahead

Read more
10 Jul 2015 11:07

LONDON MARKET MIDDAY: Wall Street To Follow Europe And China Gains

Read more
10 Jul 2015 10:21

WINNERS & LOSERS SUMMARY: InterContinental Hotels Up On Hong Kong Sale

Read more
10 Jul 2015 09:05

ReNeuron raises £68.4m with Woodford support as annual losses widen

Stem cell therapy company Reneuron Group has raised £68.4m to focus on its core product and nanomedicine cancer programme through to the first half of 2019, while final results highlighted progress of its other projects. A placing of £68.4m at a price of 5p per share saw star UK fund manager Neil Wo

Read more
10 Jul 2015 06:49

ReNeuron Annual Loss Widens As It Raises GBP68.4 Million (ALLISS)

Read more
22 Jun 2015 10:20

WINNERS & LOSERS: Savannah Resources Jumps On Deal With Rio Tinto

Read more
22 Jun 2015 07:39

ReNeuron Extends Research Deal With Benitec Following Good Results

Read more
22 May 2015 07:12

LONDON MORNING BRIEFING: Building Supply Stocks Buoyed By Upgrades

Read more
22 May 2015 06:58

ReNeuron Gets Fast Track Designation For Retinitis Pigmentosa Product

Read more
5 May 2015 06:55

ReNeuron Gets Approval For US Trial For Retinal Cell Therapy Product

Read more
17 Apr 2015 11:25

ReNeuron Sees Positive Data From Long Term Follow-Up Of CTX Trial

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.